It’s exciting to see how this unpicks the differences in risk of dementia for men and women and could contribute to our understanding of how our genes provide resilience to Alzheimer’s disease.

Alzheimer's Society responds to Alzheimer's disease treatment priority review.

New research suggests that there are 12 factors that increase the risk of dementia, but measures can be taken to reduce this risk.

Researchers at the Alzheimer’s Association International Conference have suggested that efforts aimed at reducing dementia risk may need to begin earlier in life with a focus on obesity prevention and treatment

Risk factors for Alzheimer’s may be apparent as early as our teens and 20s, according to new research reported at the Alzheimer’s Association International Conference.

Presented at AAIC, the research suggests this biomarker may detect Alzheimer's disease before symptoms appear.

New figures today published by the Office for National Statistics have revealed that more people have been helping others outside their household through the coronavirus.

Alzheimer's Society comments on Biogen submitting a licence application with the FDA for potential new Alzheimer's disease treatment, aducanumab.

With the sector estimating that it will take 4.5 years for medical research spend to return to normal levels, we are calling for emergency financial support from the Government so we can continue funding our life-saving research.

Alzheimer's Society comments on a study revealing the risk of dementia doubles for inflammatory bowel disease patients.